- Nov 11
- 3:30-5:30 pm ET
Texas Children’s Cancer and Hematology Centers is now open to enrollment in SARC024 (Regorafenib/Refractory Liposarcoma, Osteogenic Sarcoma, Ewing/Ewing-like Sarcomas). Click “Read more” for more information about SARC024.
Steven Ziemba joined SARC in September 2021 as Research Manager. Steven earned his PhD in Healthcare Administration from Capella University, Minneapolis, MN